NASDAQ: EOLS
Evolus Inc Stock Ownership - Who owns Evolus?

Insider buying vs selling

Have Evolus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tomoko YamagishidresslerChief Marketing Officer2025-08-225,722$7.51
$42.97kSell
Brady StewartDirector2025-08-1530,000$6.82
$204.48kBuy
David MoatazediPresident Chief Executive Officer2025-06-1616,582$9.89
$164.05kSell
David MoatazediPresident Chief Executive Officer2025-06-13111,323$10.05
$1.12MSell
Albert G. White IiiDirector2025-06-0920,000$9.45
$189.00kBuy
Sandra BeaverChief Financial Officer2025-05-136,494$10.02
$65.07kSell
Rui AvelarChief Medical Officer Head of Research and Development2025-05-123,385$9.87
$33.40kSell
David MoatazediPresident Chief Executive Officer2025-05-1215,787$9.87
$155.75kSell
David MoatazediPresident and Chief Executive Officer2025-03-276,251$12.40
$77.51kSell
Rui AvelarOfficer2025-03-1827,904$13.26
$369.87kSell

1 of 2

EOLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EOLS insiders and whales buy or sell their stock.

EOLS Shareholders

What type of owners hold Evolus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medytox Inc16.45%10,640,826$76.51MInsider
Tang Capital Management LLC7.73%4,997,399$35.93MInstitution
Alphaeon 1 LLC6.52%4,214,871$30.30MInsider
Nantahala Capital Management LLC6.49%4,197,926$30.18MInstitution
Blackrock Inc6.47%4,184,056$30.08MInstitution
Caligan Partners LP5.17%3,341,970$24.03MInstitution
Vanguard Group Inc5.13%3,318,250$23.86MInstitution
Perceptive Advisors LLC3.83%2,474,843$17.79MInstitution
Frazier Life Sciences Management LP3.77%2,435,550$17.51MInstitution
Soleus Capital Management LP3.28%2,119,000$15.24MInstitution

1 of 3

EOLS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EOLS76.74%23.26%Net SellingNet Buying
EBS44.23%55.77%Net SellingNet Selling
KMDA10.05%0.00%
ETON61.71%33.14%Net SellingNet Selling
AQST47.76%7.74%Net SellingNet Selling

Evolus Stock Ownership FAQ

Who owns Evolus?

Evolus (NASDAQ: EOLS) is owned by 90.14% institutional shareholders, 27.32% Evolus insiders, and 0.00% retail investors. Medytox Inc is the largest individual Evolus shareholder, owning 10.64M shares representing 16.45% of the company. Medytox Inc's Evolus shares are currently valued at $70.55M.

If you're new to stock investing, here's how to buy Evolus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.